Stay updated on Daratumumab for Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision in the footer was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T03:11:00.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Results have been posted for this study, including MRD negativity rates after ASCT and after consolidation/maintenance, progression-free and overall survival, overall response rate, adverse events, and MRD testing methods, with corresponding data submission dates.
    Difference
    2%
    Check dated 2026-03-12T21:34:09.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Results Submitted is now displayed on the study page, replacing the previous 'No Results Posted' status.
    Difference
    0.1%
    Check dated 2026-02-19T09:00:23.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T06:14:40.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study status was updated to Completed and the record now includes the Study Protocol and Statistical Analysis Plan (Revision: v3.4.1).
    Difference
    0.9%
    Check dated 2026-02-05T04:43:35.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    These are minor UI/text updates: adding 'Show glossary', capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T00:43:04.000Z thumbnail image

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.